BetterLife Pharma (BETRF) Other Non Operating Income (2010 - 2026)

BetterLife Pharma's Other Non Operating Income history runs 17 years deep, the most recent figure standing at $17306.8 for Q2 2026.

• In Q2 2026, Other Non Operating Income rose 115.39% year-over-year to $17306.8; the TTM figure through Apr 2026 stood at -$92694.9 (down 109.82% YoY), while the FY2026 annual figure was $68325.1, down 92.96% from the prior year.
• Other Non Operating Income for Q2 2026 stood at $17306.8, up from $7405.2 in the prior quarter.
• The five-year high for Other Non Operating Income was $1.0 million in Q4 2024, with the low at -$112481.6 in Q2 2025.
• The 5-year median for Other Non Operating Income is $17068.6 (2022), against an average of $103027.3.
• Peak annual rise in Other Non Operating Income reached 568.55% in 2023, while the deepest fall reached 489.94% in 2023.
• BetterLife Pharma's Other Non Operating Income stood at -$101166.6 in 2022, then jumped by 568.55% to $474019.0 in 2023, then jumped by 114.95% to $1.0 million in 2024, then tumbled by 99.27% to $7405.2 in 2025, then jumped by 133.71% to $17306.8 in 2026.
• Business Quant data shows BETRF's Other Non Operating Income at $17306.8 in Q2 2026, $7405.2 in Q3 2025, and -$112481.6 in Q2 2025.